Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

September-October 2026 (Vol. 23 Issue 5) Table of Contents
Cancer Genomics - Proteomics: 23 (5)

Issue highlights

  • ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma
  • CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue
  • Multi-level Transcriptomic and Machine-learning Analyses Identify MZT1 as a Proliferation-associated Prognostic Marker in Lung Adenocarcinoma
  • Integrated Immunotherapy Target Atlas for Ewing Sarcoma
  • Tumor Suppressive Role of Hsa-miR-328-3p in Colon Cancer by Regulating EN2

 


 

Featured Articles

  • Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human...
    September 04, 2017
  • The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan
    April 25, 2018
  • Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor...
    October 28, 2019
  • WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma
    December 26, 2015
  • Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical...
    December 26, 2015
  • ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and...
    March 01, 2018

Latest Articles

  • Open Access
    ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma
    LINGMIN SHAO, JIA LIU, MOHAMMAD ROHUL AMIN and ZHIHONG JIAN
    Cancer Genomics & Proteomics September 2026, 23 (5) 914-933; DOI: https://doi.org/10.21873/cgp.20608
  • Open Access
    Multi-level Transcriptomic and Machine-learning Analyses Identify MZT1 as a Proliferation-associated Prognostic Marker in Lung Adenocarcinoma
    DAHLAK DANIEL SOLOMON, HUI-RU LIN, YUNG-KUO LEE, SACHIN KUMAR, CHING-CHUNG KO, KAI-FU CHANG, CHUNG-HSIEN LIN, NGOC UYEN NHI NGUYEN, DO THI MINH XUAN, NEETHU PALEKKODE, CHIH-YANG WANG and YUN-SHIH LIN
    Cancer Genomics & Proteomics September 2026, 23 (5) 996-1020; DOI: https://doi.org/10.21873/cgp.20613
  • Open Access
    CTGF/CCN2 Promotes Invasive Growth in Cervical Cancer Spheroids and Is Associated With Metastatic Cervical Cancer Tissue
    LINDA VON DER BRELIE, NESIBE GÖKÇE KALYONCU, JULIA GALLWAS and CARSTEN GRÜNDKER
    Cancer Genomics & Proteomics September 2026, 23 (5) 934-947; DOI: https://doi.org/10.21873/cgp.20609
  • Open Access
    Integrated Immunotherapy Target Atlas for Ewing Sarcoma
    COREY GOLDMAN
    Cancer Genomics & Proteomics September 2026, 23 (5) 856-879; DOI: https://doi.org/10.21873/cgp.20605
  • Open Access
    Tumor Mutational Landscape and Its Correlation With Histopathological Characteristics in Breast Cancer
    EIRINI PAPADOPOULOU, MAROULIO STATHOULOPOULOU, MARIA MATIATOU, PANAGIOTIS KARATHANASIS, XENOFON XENAKIS, GRIGORIOS PESMATZOGLOU, IOANNIS FYSSAS, KONSTANTINOS LOUIS, DIMITRIOS MANIATIS, ANASTASIA EKMEKTZOGLOU, DIMITRIOS ALEXANDROU, CHRISTOS KALIVOPOULOS, CHRISTOS KANISTRAS, NIKOLAOS KATSIAKIS, IOANNA KONSTANTIADOU, CHRISTOS KAVAZIS, ATHANASIOS KOKOLAKIS, NIKOLAOS PAPAIOANNOU, ANNA SACHOULIDOU, ELEFTHERIOS SFAKIANAKIS, SOFIA TRIANTAFYLLIDOU, SOFIA FILIPPIDOU, CHRISTOS DAMASKOS, GEORGE LAZARIDIS, FILIPPOS KOINIS, EIRINI BIZIOTA, ANGELOS KOUTRAS, AIKATERINI KOTSORI and VASSILEIOS VENIZELOS
    Cancer Genomics & Proteomics September 2026, 23 (5) 1061-1081; DOI: https://doi.org/10.21873/cgp.20616
  • Open Access
    Tumor Suppressive Role of Hsa-miR-328-3p in Colon Cancer by Regulating EN2
    YUN JU LEE, DU HYEONG LEE, HYEON-SU JEONG, HYUN-YOUNG ROH, GA-RAM JEONG and HEUI-SOO KIM
    Cancer Genomics & Proteomics September 2026, 23 (5) 948-963; DOI: https://doi.org/10.21873/cgp.20610
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile

Access CGP at your Mobile Device

Now you can access the entire contents of Cancer Genomics & Proteomics at your Android or iOS device with our newly designed mobile app, freely available through Google Play and App Store.

 

​

Visit the official website of Cancer Genomics & Proteomics.
Back to top
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire